When available, the Online Course format is included with the hard copy, eBook, or audio book formats!
Release Date: September 27, 2017
Expiration Date: September 30, 2020
Skin cancer is a major public health problem. There are more than 5.4 million cases of basal cell skin cancer, squamous cell skin cancer, Merkel cell skin cancer, keratoacanthoma, dermatofibrosarcoma protuberans, and cutaneous lymphoma skin cancer annually, and the incidence rates of melanoma have been increasing for at least the past 30 years. However, most basal cell skin cancer, squamous cell skin cancer, Merkel cell skin cancers, keratoacanthomas, dermatofibrosarcoma protuberans, and cutaneous lymphoma skin cancers can be cured if the cancer is detected and treated early.
The purpose of this course is to provide nurses with an overview of the prevalence and management of skin cancer. This course will enable nurses to better understand skin cancer and the nursing care needs of patients and their families. Topics discussed include an overview of the epidemiology of skin cancer, modifiable and non-modifiable risk factors, risk assessment, prevention strategies, strengths and limitations of detection strategies, diagnosis, staging, and standard treatment modalities, including surgery, chemotherapy, and immunotherapy. A case study at the end of the course will help to illustrate the content.
This course is an extract of, and should not be taken in conjunction with N1755 - Cancer in Women, 3rd Edition
- Describe the epidemiology of all types of skin cancer and risk factors for its development.
- Explain strategies to prevent all types of skin cancer.
- Describe the diagnostic workup and staging schemas for benign and malignant skin cancers.
- Explain treatment modalities for benign and malignant skin cancers.
Suzanne Mahon, RN, DNSc, AOCN, AGN-BC, has more than 35 years of oncology experience focusing primarily on cancer prevention, early detection, and genetics. She has authored more than 200 publications in peer-reviewed journals. Dr. Mahon is a frequent speaker for both the public and healthcare professionals on cancer-related topics.
- Courses must be completed on or before the expiration date noted in the course description above.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.